The global market for cell therapies shows no sign of slowing down.
Whether it's CAR-T cells for cancer therapy, gene therapy applications, or another infusion of living cells, developing cell products comes with novel challenges in developing, testing, and manufacturing them. Even though a “one-size-fits-all” approach doesn’t work for developing cell therapies, as each are unique, there are common considerations you should be mindful of.
Learn about the most essential steps and tools to help optimize your cell therapy.
David Harris, PhD
Research Director, Charles River
Sanne Holt, PhD
Group Leader, Charles River
Dominic Clarke, PhD
Global Head of Cell Therapy, HemaCare, A Charles River Company
- Video: In Vitro Cytotoxicity Testing of CAR-T Cells
- Eureka Blog: Predictive Toxicology in the Era of CAR-T and TCR Drugs
- Antibody Library Screening Platform
We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.